Back

Most recent ESC/EAS dyslipidemia guidelines and current treatment gap

8 November 2019 (17:15 - 17:30)
Organised by:
Congress Presentation Part of: State-of-the-art lipid treatment in high-risk patients Clinical Skills, Other ESC Premium Access ESC Asia with APSC & AFC

About the speaker

Photo
Doctor Anselm Kai Gitt

Klinikum Ludwigshafen, Ludwigshafen (Germany)

3 More presentations in this session

Presentation thumbnail
State-of-the-art lipid-lowering combination therapies
Doctor D. Quek (Kuala Lumpur, MY)
Slides
Presentation thumbnail
Challenges in clinical practice: how to succeed
Professor D. Hare (Melbourne, AU)
Slides
Presentation thumbnail
Discussion and questions and answers
Professor K. Poh (Singapore, SG)

Access the full session

Session thumbnail
State-of-the-art lipid treatment in high-risk patients

The Event

Event poster

ESC Asia with APSC & AFC

8 November 2019 17:15 CET
You may be interested in
thumbnail
Webinar
Update of the 2019 ESC Guidelines on Management of Dyslipidaemia: new recommendations and their impact on clinical practice
25 November 2025
thumbnail
Congress Presentation
Icosapent ethyl in clinical practice: the Spanish experience
29 August 2025
thumbnail
Congress Presentation
The association between dyslipidaemia treatment and the risk of clinical events in edoxaban-treated patients with atrial fibrillation: insights from the 2-year follow-up of ETNA-AF-Europe
28 August 2022
thumbnail
Congress Presentation
Awareness of lipid guideline recommendations for high-risk patients amongst primary care physicians in Canada
28 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources